Welcome to PS-Pomalidomide REMS

Important information about pomalidomide and PS-Pomalidomide Risk Evaluation and Mitigation Strategy (REMS)

• Pomalidomide is contraindicated in pregnant females and females capable of becoming pregnant. Females of reproductive potential may be treated with pomalidomide provided adequate precautions are taken to avoid pregnancy
• To avoid embryo-fetal exposure, pomalidomide is only available under a restricted distribution program called “PS-Pomalidomide REMS”
• Only prescribers and pharmacies certified by PS-Pomalidomide REMS can prescribe and dispense pomalidomide to patients who are enrolled and meet all the conditions of PS-Pomalidomide REMS

The goals of the PS-Pomalidomide REMS are as follows:

1. To prevent the risk of embryo-fetal exposure to pomalidomide
2. To inform prescribers, patients, and pharmacists of the serious risks and safe-use conditions for pomalidomide